Stock investors of Central Pharmaceuticals have been unsettled after the auditor of the listed drug maker issued an adverse opinion, warning of significant uncertainty over the company’s ability to ...

Treasury Wine Estates’ new billionaire French shareholder was known to the company before he surfaced this week with a hefty ...

Small businesses are juggling too many AI tools. Learn how to audit your AI stack, cut redundant subscriptions, and stop AI ...

While postgraduate STEM courses continue to dominate Indian study-abroad choices, 2025 data shows a clear shift towards ...

That doesn't mean they can't turn into outperformers in 2026. In fact, now may be a great opportunity to buy into two AI stocks that are down 30% and 73%, respectively, from their recent high prices ...

Christmas has arrived in Verde Valle and the Chivas de Guadalajara management already has their letter to Santa Claus ready ...

The company's vertical business model is the key to understanding its prospects.

We explore how Africa’s booming creative industry is transforming cultural influence into hard, bankable collateral while Dar ...

Headlines regarding the battle for Warner Bros. just scratch the surface of how busy this year has been for the media ...

Merry Christmas! Take a look back on some of the most important environment and agriculture stories of 2025. The next year is sure to bring far more on these issues and more.

A year ago, the stock managed to rise 4.26% annually. In 2023 and 2024, ITC stock rose 39% and 5%, respectively.

AI, compound interest—and friends in high places—have made these companies billionaire factories. In January 2025, as it was ...